A new antiretroviral drug regimen has been given the go-ahead by the World Health Organisation. Preliminary results from studies that include an ongoing trial in South Africa show that dolutegravir is an effective and well-tolerated antiretroviral drug. The results are important because the Johannesburg trial includes a population representative of the real-world populations being treated for HIV across lower- and middle-income countries.
ARV Breakthrough - Trial Confirms Effectiveness of New Drug
The Conversation Africa, 25 July 2019
A new antiretroviral drug regimen has been given the go-ahead by the World Health Organisation. This follows the preliminary results from studies that include an ongoing trial in… Read more »
HIV Drug Studies Offer Patients More Choices
GroundUp, 26 July 2019
But new regimens are not problem-free Read more »
380,000 HIV Patients Enrolled On New Drug
Monitor, 24 July 2019
The Ministry of Health has shifted a total of 380,000 people living with HIV/Aids on the new effective Dolutegravir (DTG) anti-Aids drug as the preferred first-line and second-line… Read more »
About 1.7 million people worldwide became newly infected with HIV in 2018, a 16% decline since 2010, a new report by UNAIDS says. The report was launched at a community event in ... Read more »
AllAfrica publishes around 600 reports a day from more than 150 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.
AllAfrica is a voice of, by and about Africa - aggregating, producing and distributing 600 news and information items daily from over 150 African news organizations and our own reporters to an African and global public. We operate from Cape Town, Dakar, Abuja, Monrovia, Nairobi and Washington DC.